CHARACTERIZATION OF TUMORS AND TIL FROM TUMORS INDUCED BY HHV-6
HHV-6 诱导的肿瘤和 TIL 的特征
基本信息
- 批准号:3804729
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:cell mediated lymphocytolysis test cellular immunity cytotoxic T lymphocyte host neoplasm interaction human herpesvirus 6 laboratory mouse metastasis neoplasm /cancer immunology neoplasm /cancer immunotherapy oncogenic virus tissue /cell culture transfection transforming virus tumor antigens viral carcinogenesis virus related neoplasm /cancer
项目摘要
We have published results which indicated that tumors induced by HHV-6 DNA
are tumorigenic in immunocompetent NIH-Swiss mice and tumor specific TIL
can be generated from these tumors. The metastatic potential of NIH Swiss
derived tumor is currently being studied. Since NIH Swiss mice are
outbred mice, we are also currently pursuing our research to generate
tumors by transfecting HHV-6 DNA into Balb/C or C57BL/6 mice-derived
cells. Generation of tumors and TILs from inbred mice will be necessary
before attempts are made to identify tumor associated antigens in vivo and
in vitro. This project is still active.
我们已经发表的结果表明,HHV-6 DNA诱导肿瘤
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R PURI其他文献
R PURI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R PURI', 18)}}的其他基金
INTERLEUKINS AND THEIR RECEPTORS IN TUMOR BIOLOGY AND AIDS
肿瘤生物学和艾滋病中的白细胞介素及其受体
- 批准号:
6161309 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-4 RECEPTORS ON MURINE SOLID TUMORS AND TUMOR INFILTRATING LYMPHOCYTES
鼠实体瘤和肿瘤浸润淋巴细胞上的 IL-4 受体
- 批准号:
3804728 - 财政年份:
- 资助金额:
-- - 项目类别:
EFFECT OF IFN-ALPHA AND IL-2 ON IN-VIVO GENERATION OF KILLER CELLS
IFN-α和IL-2对体内杀伤细胞生成的影响
- 批准号:
3811184 - 财政年份:
- 资助金额:
-- - 项目类别:
INTERLEUKINS AND THEIR RECEPTORS IN TUMOR BIOLOGY AND AIDS
肿瘤生物学和艾滋病中的白细胞介素及其受体
- 批准号:
2568987 - 财政年份:
- 资助金额:
-- - 项目类别:
INTERLEUKIN-4 AND THEIR RECEPTORS IN TUMOR BIOLOGY AND AIDS
肿瘤生物学和艾滋病中的 INTERLEUKIN-4 及其受体
- 批准号:
3770375 - 财政年份:
- 资助金额:
-- - 项目类别:
INTERLEUKIN-4 AND THEIR RECEPTORS IN TUMOR BIOLOGY AND AIDS
肿瘤生物学和艾滋病中的 INTERLEUKIN-4 及其受体
- 批准号:
5200774 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10448950 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Gingival vaccination strategy to induce both humoral and cellular immunity ideal for elderly vaccination
诱导体液和细胞免疫的牙龈疫苗接种策略非常适合老年人疫苗接种
- 批准号:
22K09932 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10508093 - 财政年份:2022
- 资助金额:
-- - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10501418 - 财政年份:2022
- 资助金额:
-- - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10650823 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
-- - 项目类别:
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
- 批准号:
10449406 - 财政年份:2022
- 资助金额:
-- - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10797812 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
-- - 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10662571 - 财政年份:2022
- 资助金额:
-- - 项目类别: